Your browser doesn't support javascript.
loading
Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2.
Ai, Liangxia; Li, Yafei; Zhou, Li; Yao, Wenrong; Zhang, Hao; Hu, Zhaoyu; Han, Jinyu; Wang, Weijie; Wu, Junmiao; Xu, Pan; Wang, Ruiyue; Li, Zhangyi; Li, Zhouwang; Wei, Chengliang; Liang, Jianqun; Chen, Haobo; Yang, Zhimiao; Guo, Ming; Huang, Zhixiang; Wang, Xin; Zhang, Zhen; Xiang, Wenjie; Sun, Dazheng; Xu, Lianqiang; Huang, Meiyan; Lv, Bin; Peng, Peiqi; Zhang, Shangfeng; Ji, Xuhao; Luo, Huiyi; Chen, Nanping; Chen, Jianping; Lan, Ke; Hu, Yong.
Afiliação
  • Ai L; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Li Y; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Zhou L; State Key Laboratory of Virology, College of Life Sciences, ABSL-3 Laboratory/Institute for Vaccine Research, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, China.
  • Yao W; Jiangsu Rec-biotechnology Co. Ltd., Taizhou, Jiangsu, China.
  • Zhang H; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Hu Z; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Han J; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Wang W; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Wu J; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Xu P; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Wang R; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Li Z; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Li Z; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Wei C; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Liang J; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Chen H; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Yang Z; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Guo M; State Key Laboratory of Virology, College of Life Sciences, ABSL-3 Laboratory/Institute for Vaccine Research, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, China.
  • Huang Z; State Key Laboratory of Virology, College of Life Sciences, ABSL-3 Laboratory/Institute for Vaccine Research, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, China.
  • Wang X; State Key Laboratory of Virology, College of Life Sciences, ABSL-3 Laboratory/Institute for Vaccine Research, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, China.
  • Zhang Z; State Key Laboratory of Virology, College of Life Sciences, ABSL-3 Laboratory/Institute for Vaccine Research, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, China.
  • Xiang W; State Key Laboratory of Virology, College of Life Sciences, ABSL-3 Laboratory/Institute for Vaccine Research, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, China.
  • Sun D; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Xu L; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Huang M; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Lv B; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Peng P; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Zhang S; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Ji X; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Luo H; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Chen N; Shenzhen Rhegen Biotechnology Co. Ltd., Shenzhen, Guangdong, China.
  • Chen J; Jiangsu Rec-biotechnology Co. Ltd., Taizhou, Jiangsu, China. chenjp@recbio.cn.
  • Lan K; Wuhan Recogen Biotechnology Co. Ltd., Wuhan, Hubei, China. chenjp@recbio.cn.
  • Hu Y; State Key Laboratory of Virology, College of Life Sciences, ABSL-3 Laboratory/Institute for Vaccine Research, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, China. klan@whu.edu.cn.
Cell Discov ; 9(1): 9, 2023 Jan 23.
Article em En | MEDLINE | ID: mdl-36683074
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article